mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for GNAI3
Gene summary
Basic gene Info.Gene symbolGNAI3
Gene nameguanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
Synonyms87U6|ARCND1
CytomapUCSC genome browser: 1p13
Type of geneprotein-coding
RefGenesNM_006496.3,
Descriptiong(i) alpha-3guanine nucleotide-binding protein G(k) subunit alpha
Modification date20141207
dbXrefs MIM : 139370
HGNC : HGNC
HPRD : 00765
ProteinUniProt: P08754
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_GNAI3
BioGPS: 2773
PathwayNCI Pathway Interaction Database: GNAI3
KEGG: GNAI3
REACTOME: GNAI3
Pathway Commons: GNAI3
ContextiHOP: GNAI3
ligand binding site mutation search in PubMed: GNAI3
UCL Cancer Institute: GNAI3
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0051301cell division17635935


Top
Ligand binding site mutations for GNAI3
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
E238E238KBLCA1
Q147Y146FCOAD1
R242R242QHNSC1
F259T260ASTAD1
T327D328GUCEC1
I212H213NUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for GNAI3
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R242R242Q-1.2363725
I212H213N-1.0972841
F259T260A-1.020324
T327D328G-0.78082898
Q147Y146F-0.57223568
E238E238K-0.55001523
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for GNAI3 from PDB

Top
Differential gene expression and gene-gene network for GNAI3
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of GNAI3 and the right PPI network was created from samples without mutations in the LBS of GNAI3. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for GNAI3
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C1865295Auriculo-condylar syndrome3Biomarker, GeneticVariation
umls:C0002622Amnesia1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for GNAI3
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of GNAI3 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
IIIPeptide ligand (GLU,ASP,PHE,PHE,SER,LEU,ILE,LEU,ARG,SER,GLN,ALA,LYS,ARG,MET,ASP,GLU,GLN,ARG,VAL,LEU,LEU)4g5oBE238 F259
IIIPeptide ligand (GLU,ASP,PHE,PHE,SER,LEU,ILE,LEU,ARG,SER,GLN,ALA,LYS,ARG,MET,ASP,GLU,GLN,ARG,VAL,LEU,LEU)4g5oAF259
IIIPeptide ligand (GLU,ASP,PHE,PHE,SER,LEU,ILE,LEU,ARG,SER,GLN,ALA,LYS,ARG,MET,ASP,GLU,GLN,ARG,VAL,LEU,LEU)4g5oCI212 F259
IIIPeptide ligand (ASP,PHE,PHE,SER,LEU,ILE,LEU,ARG,SER,GLN,ALA,LYS,ARG,MET,ASP,GLU,GLN,ARG,VAL,LEU,LEU)4g5rDQ147
IIIPeptide ligand (ASP,PHE,PHE,ASP,ILE,LEU,VAL,LYS,CYS,GLN,GLY,SER,ARG,LEU,ASP,ASP,GLN,ARG,CYS,ALA,PRO,PRO)4g5sAQ147
IIIPeptide ligand (ASP,PHE,PHE,ASP,ILE,LEU,VAL,LYS,CYS,GLN,GLY,SER,ARG,LEU,ASP,ASP,GLN,ARG,CYS,ALA,PRO,PRO)4g5sBQ147
IIIPeptide ligand (SER,ARG,LEU,ASP,ASP,GLN,ARG,CYS,ALA,PRO,PRO)4g5sCQ147
IIIPeptide ligand (ARG,LEU,ASP,ASP,GLN,ARG,CYS,ALA,PRO,PRO)4g5sDQ147
IIIPeptide ligand (ASP,PHE,PHE,SER,LEU,ILE,LEU,ARG,SER,GLN,ALA,LYS,ARG,MET,ASP,GLU,GLN,ARG,VAL,LEU,LEU,GLN)4g5rBQ147 F259
IIIPeptide ligand (ASP,PHE,PHE,SER,LEU,ILE,LEU,ARG,SER,GLN,ALA,LYS,ARG,MET,ASP,GLU,GLN,ARG,VAL,LEU,LEU)4g5rAQ147 R242
IIIPeptide ligand (ASP,PHE,PHE,SER,LEU,ILE,LEU,ARG,SER,GLN,ALA,LYS,ARG,MET,ASP,GLU,GLN,ARG,VAL,LEU,LEU,GLN)4g5rCQ147 R242
GDPGUANOSINE-5'-DIPHOSPHATE2ihbAT327
GDPGUANOSINE-5'-DIPHOSPHATE2odeAT327
GDPGUANOSINE-5'-DIPHOSPHATE2odeCT327
GDPGUANOSINE-5'-DIPHOSPHATE2v4zAT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5oAT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5oBT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5oCT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5oDT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5rAT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5rBT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5rCT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5rDT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5sAT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5sBT327
GDPGUANOSINE-5'-DIPHOSPHATE4g5sCT327


Top
Conservation information for LBS of GNAI3
Multiple alignments for P08754 in multiple species
LBSAA sequence# speciesSpecies
A326THFTCATDTKN3Homo sapiens, Mus musculus, Rattus norvegicus
A41LLLLGAGESGK3Homo sapiens, Mus musculus, Rattus norvegicus
A83IQSIIAIIRAM3Homo sapiens, Mus musculus, Rattus norvegicus
C325YTHFTCATDTK3Homo sapiens, Mus musculus, Rattus norvegicus
D272FLNKKDLFEEK3Homo sapiens, Mus musculus, Rattus norvegicus
E207GGQRSERKKWI3Homo sapiens, Mus musculus, Rattus norvegicus
E238VLAEDEEMNRM3Homo sapiens, Mus musculus, Rattus norvegicus
E239LAEDEEMNRMH3Homo sapiens, Mus musculus, Rattus norvegicus
E245MNRMHESMKLF3Homo sapiens, Mus musculus, Rattus norvegicus
E43LLGAGESGKST3Homo sapiens, Mus musculus, Rattus norvegicus
F215KWIHCFEGVTA3Homo sapiens, Mus musculus, Rattus norvegicus
F259CNNKWFTDTSI2Mus musculus, Rattus norvegicus
F259CNNKWFTETSI1Homo sapiens
G202KMFDVGGQRSE3Homo sapiens, Mus musculus, Rattus norvegicus
G203MFDVGGQRSER3Homo sapiens, Mus musculus, Rattus norvegicus
G40KLLLLGAGESG3Homo sapiens, Mus musculus, Rattus norvegicus
G42LLLGAGESGKS3Homo sapiens, Mus musculus, Rattus norvegicus
G45GAGESGKSTIV3Homo sapiens, Mus musculus, Rattus norvegicus
I212ERKKWIHCFEG3Homo sapiens, Mus musculus, Rattus norvegicus
I253KLFDSICNNKW3Homo sapiens, Mus musculus, Rattus norvegicus
K180LRTRVKTTGIV3Homo sapiens, Mus musculus, Rattus norvegicus
K270ILFLNKKDLFE3Homo sapiens, Mus musculus, Rattus norvegicus
K46AGESGKSTIVK3Homo sapiens, Mus musculus, Rattus norvegicus
L148SREYQLNDSAS3Homo sapiens, Mus musculus, Rattus norvegicus
L249HESMKLFDSIC3Homo sapiens, Mus musculus, Rattus norvegicus
L273LNKKDLFEEKI3Homo sapiens, Mus musculus, Rattus norvegicus
L39VKLLLLGAGES3Homo sapiens, Mus musculus, Rattus norvegicus
N149REYQLNDSASY3Homo sapiens, Mus musculus, Rattus norvegicus
N256DSICNNKWFTD2Mus musculus, Rattus norvegicus
N256DSICNNKWFTE1Homo sapiens
N269IILFLNKKDLF3Homo sapiens, Mus musculus, Rattus norvegicus
N76VVVYSNTIQSI3Homo sapiens, Mus musculus, Rattus norvegicus
Q147RSREYQLNDSA3Homo sapiens, Mus musculus, Rattus norvegicus
Q204FDVGGQRSERK3Homo sapiens, Mus musculus, Rattus norvegicus
Q79YSNTIQSIIAI3Homo sapiens, Mus musculus, Rattus norvegicus
R176QQDVLRTRVKT3Homo sapiens, Mus musculus, Rattus norvegicus
R178DVLRTRVKTTG3Homo sapiens, Mus musculus, Rattus norvegicus
R205DVGGQRSERKK3Homo sapiens, Mus musculus, Rattus norvegicus
R208GQRSERKKWIH3Homo sapiens, Mus musculus, Rattus norvegicus
R242DEEMNRMHESM3Homo sapiens, Mus musculus, Rattus norvegicus
S151YQLNDSASYYL3Homo sapiens, Mus musculus, Rattus norvegicus
S206VGGQRSERKKW3Homo sapiens, Mus musculus, Rattus norvegicus
S252MKLFDSICNNK3Homo sapiens, Mus musculus, Rattus norvegicus
S44LGAGESGKSTI3Homo sapiens, Mus musculus, Rattus norvegicus
S47GESGKSTIVKQ3Homo sapiens, Mus musculus, Rattus norvegicus
S75KVVVYSNTIQS3Homo sapiens, Mus musculus, Rattus norvegicus
T181RTRVKTTGIVE3Homo sapiens, Mus musculus, Rattus norvegicus
T327HFTCATDTKNV3Homo sapiens, Mus musculus, Rattus norvegicus
T48ESGKSTIVKQM3Homo sapiens, Mus musculus, Rattus norvegicus
V179VLRTRVKTTGI3Homo sapiens, Mus musculus, Rattus norvegicus
V201FKMFDVGGQRS3Homo sapiens, Mus musculus, Rattus norvegicus
V72KQYKVVVYSNT3Homo sapiens, Mus musculus, Rattus norvegicus
W211SERKKWIHCFE3Homo sapiens, Mus musculus, Rattus norvegicus
W258ICNNKWFTDTS2Mus musculus, Rattus norvegicus
W258ICNNKWFTETS1Homo sapiens
Y69DECKQYKVVVY3Homo sapiens, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas